Immunovo

Netherlands
's-Hertogenbosch, North Brabant, The Netherlands, 5223

Company profile

Immunovo company profile

Immunovo BV is a Dutch private biotechnology company, based in ‘s-Hertogenbosch, engaged in the discovery and clinical development of immunotherapeutics in the field of oncology. The key priority for Immunovo is on its proprietary Immune Activation System (IAS) based on combining synthetic peptide antigens with a novel immune stimulant (adjuvant).

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2009-01-01, Year

Headquarters

Postal code
5223
Country code
NL
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Last funding
Seed / 2010-04-28
Last equity funding
Seed
Investors
2

Founders and investors

Investors

Biox BiosciencesLupus Ventures